EPHEDRINE SULFATE
| Brand name | EPHEDRINE SULFATE |
|---|---|
| Active ingredient | EPHEDRINE SULFATE |
| Strength | 25MG/5ML (5MG/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | April 2022 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12029710 | January 2040 | use U-3963 |
| 10869845 | January 2040 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.